Aurora Cannabis sees record Q4-2025 revenues driven by international sales, but low profits and weak 2026 outlook keep stock ...

This was the stock's fourth consecutive day of gains.

Aurora Cannabis faces headwinds as Q4/FY2025 revenues grow but profitability declines due to one-time expenses. Check out why I'm downgrading ACB stock to Buy.

Aurora Cannabis (ACB) delivered earnings and revenue surprises of -36.36% and 1.65%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Aurora Cannabis Inc (TSX:ACB) is set to release its Q4 2025 earnings on June 18, 2025. The consensus estimate for Q4 2025 ...

Q4 2025 Earnings Call Transcript June 18, 2025 Aurora Cannabis Inc. misses on earnings expectations. Reported EPS is $0.07 ...

Aurora Cannabis Q4 sales rose 34% to $63.07 million, led by medical cannabis and plant propagation, despite missing earnings estimates.

Detailed price information for Aurora Cannabis Inc (ACB-Q) from The Globe and Mail including charting and trades.

Aurora Cannabis (ACB) delivered earnings and revenue surprises of -36.36% and 1.65%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aurora Cannabis Inc. - ACB PR Newswire Jun 27, 2025, 7:00:00 AM ...